Emblaveo is a fixed-dose IV treatment that combines aztreonam, a monobactam antibiotic, and avibactam, a β-lactamase inhibitor.
Noninferior efficacy seen for three all-oral regimens compared with standard therapy in intention-to-treat, per-protocol populations
The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA) and making a final decision on marketing approval. The typical period for review is 10 months after the drug application has been…
Summary of important additions and changes to the MPR drug database.
Avtozma, formerly known as CT-P47, is an interleukin-6 receptor antagonist.
HealthDay News — A new strain of bird flu, H5N9, has been detected for the first time in the US, raising concerns about how it continues to spread. The strain was discovered at a commercial duck farm in California’s Merced County, and was reported to the World Organization for Animal Health, which maintains a database…
However, the waiver does not address resumption of other PEPFAR services
Local health officials are offering free TB testing to help control the outbreak
During October 2022 shortage, increase seen in monthly dispensing rate of dexmethylphenidate.
This funding, announced Friday by Moderna, builds on the $176 million it received from HHS last year to support earlier stages of vaccine research.
-
Top Picks
from ourHaymarket Medical Network